XML 20 R9.htm IDEA: XBRL DOCUMENT v3.19.1
Financial Instruments
3 Months Ended
Mar. 31, 2019
Investments, Debt and Equity Securities [Abstract]  
Financial Instruments
Note 2 — FINANCIAL INSTRUMENTS
Cash, Cash Equivalents, Restricted Cash, and Marketable Securities
As of December 31, 2018 and March 31, 2019, our cash, cash equivalents, restricted cash, and marketable securities primarily consisted of cash, AAA-rated money market funds, U.S. and foreign government and agency securities, and other investment grade securities. Cash equivalents and marketable securities are recorded at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To increase the comparability of fair value measures, the following hierarchy prioritizes the inputs to valuation methodologies used to measure fair value:
Level 1—Valuations based on quoted prices for identical assets and liabilities in active markets.
Level 2—Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data.
Level 3—Valuations based on unobservable inputs reflecting our own assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment.
We measure the fair value of money market funds and certain marketable equity securities based on quoted prices in active markets for identical assets or liabilities. Other marketable securities were valued either based on recent trades of securities in inactive markets or based on quoted market prices of similar instruments and other significant inputs derived from or corroborated by observable market data. We did not hold any cash, cash equivalents, restricted cash, or marketable securities categorized as Level 3 assets as of December 31, 2018 and March 31, 2019.
The following table summarizes, by major security type, our cash, cash equivalents, restricted cash, and marketable securities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy (in millions):
 
December 31, 2018
 
March 31, 2019
  
Total
Estimated
Fair Value
 
Cost or
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Total
Estimated
Fair Value
Cash
$
10,406

 
$
8,635

 
$

 
$

 
$
8,635

Level 1 securities:
 
 
 
 
 
 
 
 
 
Money market funds
12,515

 
9,515

 

 

 
9,515

Equity securities (1)
170

 
 
 
 
 
 
 
263

Level 2 securities:
 
 
 
 
 
 
 
 
 
Foreign government and agency securities
815

 
1,382

 

 

 
1,382

U.S. government and agency securities
11,667

 
8,864

 
3

 
(13
)
 
8,854

Corporate debt securities
4,990

 
7,396

 
8

 
(6
)
 
7,398

Asset-backed securities
892

 
1,166

 
3

 
(2
)
 
1,167

Other fixed income securities
188

 
201

 

 
(1
)
 
200

Equity securities (1)
33

 
 
 
 
 
 
 

 
$
41,676

 
$
37,159

 
$
14

 
$
(22
)
 
$
37,414

Less: Restricted cash, cash equivalents, and marketable securities (2)
(426
)
 
 
 
 
 
 
 
(394
)
Total cash, cash equivalents, and marketable securities
$
41,250

 
 
 
 
 
 
 
$
37,020

___________________
(1)
The related unrealized gain (loss) recorded in “Other income (expense), net” was $68 million in Q1 2019.
(2)
We are required to pledge or otherwise restrict a portion of our cash, cash equivalents, and marketable securities as collateral for real estate leases, amounts due to third-party sellers in certain jurisdictions, debt, and standby and trade letters of credit. We classify cash, cash equivalents, and marketable securities with use restrictions of less than twelve months as “Accounts receivable, net and other” and of twelve months or longer as non-current “Other assets” on our consolidated balance sheets. See “Note 4 — Commitments and Contingencies.”
The following table summarizes the remaining contractual maturities of our cash equivalents and marketable fixed income securities as of March 31, 2019 (in millions):
 
Amortized
Cost
 
Estimated
Fair Value
Due within one year
$
23,482

 
$
23,478

Due after one year through five years
4,274

 
4,277

Due after five years through ten years
190

 
190

Due after ten years
578

 
571

Total
$
28,524

 
$
28,516


Actual maturities may differ from the contractual maturities because borrowers may have certain prepayment conditions.
Equity Warrants and Non-Marketable Equity Securities
We hold equity warrants giving us the right to acquire stock of other companies. As of December 31, 2018 and March 31, 2019, these warrants had a fair value of $440 million and $594 million, and are recorded within “Other assets” on our consolidated balance sheets. The related gain (loss) recorded in “Other income (expense), net” was $45 million and $89 million in Q1 2018 and Q1 2019. These assets are primarily classified as Level 2 assets.
As of December 31, 2018 and March 31, 2019, equity securities not accounted for under the equity method and without readily determinable fair values, had a carrying value of $282 million and $888 million.
Consolidated Statements of Cash Flows Reconciliation
The following table provides a reconciliation of the amount of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets to the total of the same such amounts shown in the consolidated statements of cash flows (in millions):
 
December 31, 2018
 
March 31, 2019
Cash and cash equivalents
$
31,750

 
$
23,115

Restricted cash included in accounts receivable, net and other
418

 
359

Restricted cash included in other assets
5

 
33

Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows
$
32,173

 
$
23,507